Klimek, Ludger
Lange, Lars
Blum, Lea Alexandra
Klimek, Felix
Nemat, Katja
Reese, Imke
Blumchen, Katharina
Funding for this research was provided by:
Johann Wolfgang Goethe-Universität, Frankfurt am Main
Article History
Received: 4 October 2021
Accepted: 6 October 2021
First Online: 6 December 2021
Conflict of interest
: L. Klimek reports grants and personal fees from Allergopharma, grants and personal fees from MEDA/Mylan, personal fees from HAL, grants from ALK Abelló, grants and personal fees from LETI Pharma, grants from Stallergenes, grants from Quintiles, grants and personal fees from Sanofi, grants from ASIT biotech, grants from Lofarma, personal fees from Allergy Therapeutics, grants from AstraZeneca, grants from GSK, grants from Inmunotk, personal fees from Cassella med, outside submitted work; and membership: AeDA, DGHNO, German Academy of Allergology and Clinical Immunology, ENT-BV, GPA, EAACI. L. Lange reports on consultancy fees from Aimmune, DBV Technologies and Nestlé. He has given paid lectures for Aimmune, DBV Technologies, Nestlé and Nutricia. K. Blumchen reports personal fees from ThermoFisher Scientific; grants, personal fees, and nonfinancial support from Aimmune Therapeutics; grants, personal fees, and nonfinancial support from DBV Technologies; grants from Hipp GmbH; personal fees from Novartis; personal fees from Allergy Therapeutics; personal fees from HAL; personal fees from ALK; personal fees from Allergopharma; personal fees from Nutricia; personal fees from Nestle; personal fees from Bausch and Lomb, outside the submitted work. L.A. Blum, F. Klimek, K. Nemat and I. Reese declare that they have no competing interests.